# Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

> **NCT02226367** · NA · COMPLETED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 158 (actual)

## Conditions studied

- Alcohol Use Disorders
- Stress Disorders, Posttraumatic
- Combat Disorders

## Interventions

- **DRUG:** prazosin hydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02226367
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-09-20
- **Final completion:** 2018-10-20
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2023-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226367, "Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02226367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*